RenovoRx Inc share price logo

RenovoRx Inc

NASDAQ: RNXT

Small Cap

$0.87

-0.10

(-10.60%)

as on

RenovoRx Inc Stock Performance

as on June 6, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.88
    $0.99
    downward going graph

    -1.15%

    Downside

    13.79%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.70
    $1.45
    downward going graph

    19.47%

    Downside

    66.67%

    Upside

    downward going graph

RenovoRx Inc share price movements today

Previous Close
$0.98
Open
$0.97
Volume
1.6M
Day's Low - High
$0.88 - $0.99
52 Week Low - High
$0.70 - $1.45

RenovoRx Inc Historical Returns

1 Month Return
+ 5.07 %
3 Month Return
+ 16.05 %
1 Year Return
-30.33 %
3 Year Return
-51.47 %
5 Year Return
0 %

RenovoRx Inc Stock Fundamentals & Key Indicators

Check RenovoRx Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$41.1M

EPS (TTM)

-0.31

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-12.4M

Revenue (TTM)

1.5M

Profit Margin

0.00%

Return On Equity TTM

-100.48%

RenovoRx Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of RenovoRx Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$41.1MNANA0.00%NA
BUY$32.2B410.63%NA0.00%NA
BUY$39.1B108.54%73.5112.55%NA
BUY$108.7B110.42%25.4535.51%NA
BUY$64.9B22.83%15.1129.65%0.59%

Stock Returns calculator for RenovoRx Inc Stock including INR - Dollar returns

The RenovoRx Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

RenovoRx Inc investment value today

Current value as on today

₹68,742

Returns

-₹31,258

(-31.26%)

Returns from RenovoRx Inc Stock

-₹37,857 (-37.86%)

Dollar Impact

₹6,599 (+6.6%)

Analyst Recommendation on RenovoRx Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for RenovoRx Inc. Average target price of $7.03

RenovoRx Inc Share Price Target

Get share price movements and forecasts by analysts on RenovoRx Inc.

What analysts predicted

87.62%UPSIDE

Target Price

$7.03

Current Price

$0.87

Analyzed by

9 Analysts

Target

$7.03

RenovoRx Inc target price $7.03, a slight upside of 87.62% compared to current price of $0.87. According to 9 analysts rating.

Indian Investors' Interest in RenovoRx Inc Stock

Search interest for RenovoRx Inc Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

RenovoRx Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
0
0
0
0
0
0
Gross Profit
-
-
-
-
-
0
0
0
0
0
Operating Income
-1
-2
-3
-2
-2
-3
-2
-3
-3
-3
EBITDA
-
-2
-3
-2
-
-2
-2
-3
-3
-3
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
0
0
0
0
0
Income Before Tax
-3
-1
-2
-2
-2
-2
-2
-2
-2
-3
Income Tax Expense
-
-2
-3
-
-
2
-
-
-
-
Net Income
-3
-1
-2
-2
-2
-2
-2
-2
-2
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-6693.02%
-1228.43%
-686.02%
-1094.74%
-1235.71%
-625.40%

RenovoRx Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
0
1
Gross Profit
-
-
0
0
-
0
0
Operating Income
-3
-3
-5
-9
-11
-10
-12
EBITDA
-3
-3
-5
-9
-11
-10
-12
Interest Expense
-
0
0
0
0
0
-
Depreciation
-
-
0
0
-
-
0
Income Before Tax
-3
-3
-6
-9
-10
-8
-11
Income Tax Expense
0
0
0
0
0
-8
-
Net Income
-3
-3
-6
-9
-10
-8
-11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-20497.67%
-994.48%

RenovoRx Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-1
-2
-2
-2
-2
-2
-2
-2
-3
Operating Cash Flow
-2
-2
-2
-2
-3
-2
-2
-3
-3
Investing Cash Flow
-
-
-
-
0
-
-
-
0
Financing Cash Flow
5
9
0
0
10
0
-
-
9
Change in Cash
3
7
-2
-2
7
-2
-2
-3
5

RenovoRx Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-3
-6
-9
-10
-8
-11
Operating Cash Flow
-3
-5
-8
-10
-9
-10
Investing Cash Flow
0
0
-2
2
0
0
Financing Cash Flow
3
19
0
5
15
10
Change in Cash
0
13
-10
-3
5
0

Global Institutional Holdings in RenovoRx Inc

Funds
Holdings
HighTower Advisors, LLC
0.04%
Cetera Investment Advisers
0.04%
Renaissance Technologies Corp
0.03%
TWO SIGMA SECURITIES, LLC
0.04%
ADAR1 Capital Management LLC
0.05%

Insights on RenovoRx Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RNXT stock has moved up by 10.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 452.7% return, outperforming this stock by 506.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 263.2% return, outperforming this stock by 300.5%

About RenovoRx Inc

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.
OrganisationRenovoRx Inc
Headquarters2570 West El Camino Real, Mountain View, CA, United States, 94040
IndustryBiotechnology
CEOMr. Shaun R. Bagai
E-voting on sharesClick here to vote

Key Management of RenovoRx Inc

Name

Title

Mr. Ryan Witt

Senior VP and Head of Corporate Strategy & Partnerships

Dr. Ramtin Agah M.D.

Founder, Executive Chairman & Chief Medical Officer

Mr. Shaun R. Bagai

CEO, Secretary & Director

Mr. Ronald B. Kocak CPA, CGMA

VP of Finance & Controller

Mr. Mark Voll

CFO & Principal Accounting Officer

Mr. Robert Strasser

Vice President of Operations and R&D

Ms. Leesa Gentry

Chief Clinical Officer

FAQs

What is RenovoRx Inc share price today?

RenovoRx Inc share price today is $0.87 as on at the close of the market. RenovoRx Inc share today touched a day high of $0.99 and a low of $0.88.

What is the 52 week high and 52 week low for RenovoRx Inc share?

RenovoRx Inc share touched a 52 week high of $1.45 on and a 52 week low of $0.7 on . RenovoRx Inc stock price today i.e. is closed at $0.87,which is 40.00% down from its 52 week high and 24.18% up from its 52 week low.

What is RenovoRx Inc's market capitalisation today?

RenovoRx Inc market capitalisation is $0.00T as on .

How to invest in RenovoRx Inc Stock (RNXT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for RenovoRx Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in RenovoRx Inc Shares that will get you 1.7241 shares as per RenovoRx Inc share price of $0.87 per share as on June 6, 2026 at 8:46 am IST.

What is the minimum amount required to buy RenovoRx Inc Stock (RNXT) from India?

Indian investors can start investing in RenovoRx Inc (RNXT) shares with as little as ₹94.95 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in RenovoRx Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on RenovoRx Inc share’s latest price of $0.87 as on June 6, 2026 at 8:46 am IST, you will get 11.4943 shares of RenovoRx Inc. Learn more about fractional shares .